These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Evaluation of the effectiveness of sarpogrelate on the surrogate markers for macrovascular complications in patients with type 2 diabetes. Park SY; Rhee SY; Oh S; Kwon HS; Cha BY; Lee HJ; Lee HC; Kim YS Endocr J; 2012; 59(8):709-16. PubMed ID: 22673600 [TBL] [Abstract][Full Text] [Related]
6. Enteric-coated aspirin versus other antiplatelet drugs in acute non-cardioembolic ischemic stroke: post-marketing study in Japan. Takahashi S; Mizuno O; Sakaguchi T; Yamada T; Inuyama L Adv Ther; 2014 Jan; 31(1):118-29. PubMed ID: 24385407 [TBL] [Abstract][Full Text] [Related]
7. Study design of the influence of SErotonin inhibition on patients with RENAl impairment or diabetes undergoing drug-eluting stent implantation (SERENADE) study: A multicenter, open-label, prospective, randomized study. Lee SA; Suh JW; Park JJ; Yoon CH; Cho YS; Youn TJ; Chae IH; Kim HS; Kim SH; Choi DJ Contemp Clin Trials; 2015 Jul; 43():20-4. PubMed ID: 25891091 [TBL] [Abstract][Full Text] [Related]
8. Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial. Ikeda Y; Shimada K; Teramoto T; Uchiyama S; Yamazaki T; Oikawa S; Sugawara M; Ando K; Murata M; Yokoyama K; Ishizuka N JAMA; 2014 Dec; 312(23):2510-20. PubMed ID: 25401325 [TBL] [Abstract][Full Text] [Related]
9. Effect of sarpogrelate, a 5-HT(2A) antagonist, on platelet aggregation in patients with ischemic stroke: clinical-pharmacological dose-response study. Uchiyama S; Ozaki Y; Satoh K; Kondo K; Nishimaru K Cerebrovasc Dis; 2007; 24(2-3):264-70. PubMed ID: 17622759 [TBL] [Abstract][Full Text] [Related]
10. Prospective Randomized Study of Sarpogrelate Versus Clopidogrel-based Dual Antiplatelet Therapies in Patients Undergoing Femoropopliteal Arterial Endovascular Interventions: Preliminary Results. Chen YX; Wang WD; Song XJ; Gu YQ; Tian HY; Hu HJ; Zhao JC; Li XQ; Liu CW Chin Med J (Engl); 2015 Jun; 128(12):1563-6. PubMed ID: 26063354 [TBL] [Abstract][Full Text] [Related]
11. Comparison of warfarin versus aspirin for the prevention of recurrent stroke or death: subgroup analyses from the Warfarin-Aspirin Recurrent Stroke Study. Sacco RL; Prabhakaran S; Thompson JL; Murphy A; Sciacca RR; Levin B; Mohr JP; Cerebrovasc Dis; 2006; 22(1):4-12. PubMed ID: 16567931 [TBL] [Abstract][Full Text] [Related]
12. Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration. Simes J; Becattini C; Agnelli G; Eikelboom JW; Kirby AC; Mister R; Prandoni P; Brighton TA; Circulation; 2014 Sep; 130(13):1062-71. PubMed ID: 25156992 [TBL] [Abstract][Full Text] [Related]
13. [Clinical value of protoparaxotril saporlirs combined with aspirin in the secondary prevention of cerebral infarction]. Zhou BR; Xu ZQ; Liu ZF Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Sep; 28(9):797-800. PubMed ID: 19065892 [TBL] [Abstract][Full Text] [Related]